Search results for "perch"

showing 10 items of 1084 documents

Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 mont…

2016

Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches for the treatment of dyslipidemia. This has led to a search for alternative therapeutic approaches for dyslipidemia management. In recent studies Citrus bergamia (known as Bergamot) juice was able to reduce serum levels of lipids. Such benefit may be attributed to high amounts of flavonoids contained in Bergamot fruit juice (neoeriocitrin, neohesperidin, naringin). The aim of the present study was to fully investigate the effects of a Bergamot extract on cardio-metabolic parameters, including plasma lipids, atherogenic lipoproteins and subclinical atherosclerosis. Methods: Eighty subjects (42…

0301 basic medicinemedicine.medical_specialtyHypercholesterolemiaBergamotCarotid IMT030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineNeoeriocitrinMedicinePharmacology (medical)Prospective cohort studyNaringinOriginal ResearchLDL subclassesPharmacologyNeohesperidinbusiness.industryCholesterollcsh:RM1-950medicine.diseaseCardiovascular risklcsh:Therapeutics. Pharmacology030104 developmental biologyEndocrinologychemistryLow-density lipoproteinlipids (amino acids peptides and proteins)LDL subclassebusinessDyslipidemiaLipoprotein
researchProduct

Autosomal Recessive Hypercholesterolemia

2018

Abstract Background Autosomal recessive hypercholesterolemia (ARH) is a rare lipid disorder characterized by premature atherosclerotic cardiovascular disease (ASCVD). There are sparse data for clinical management and cardiovascular outcomes in ARH. Objectives Evaluation of changes in lipid management, achievement of low-density lipoprotein cholesterol (LDL-C) goals and cardiovascular outcomes in ARH. Methods Published ARH cases were identified by electronic search. All corresponding authors and physicians known to treat these patients were asked to provide follow-up information, using a standardized protocol. Results We collected data for 52 patients (28 females, 24 males; 31.1 ± 17.1 years…

0301 basic medicinemedicine.medical_specialtyStatinAtherosclerotic cardiovascular diseasebusiness.industrymedicine.drug_class030204 cardiovascular system & hematologyLomitapide03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineEzetimibechemistryAutosomal Recessive HypercholesterolemiaInternal medicinemedicineEffective treatmentlipids (amino acids peptides and proteins)In patientCardiology and Cardiovascular MedicinebusinessCardiovascular outcomesmedicine.drugJournal of the American College of Cardiology
researchProduct

CCDC 787305: Experimental Crystal Structure Determination

2011

Related Article: C.Bazzicalupi, A.Bencini, S.Ciattini, F.Denat, P.Desogere, C.Goze, I.Matera, B.Valtancoli|2010|Dalton Trans.|39|11643|doi:10.1039/c0dt00948b

17-(22'-(Diphenyl ether)dimethyl)-410-diazonia-17-diaza-cyclododecane diperchlorateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 127936: Experimental Crystal Structure Determination

2001

Related Article: S.Kiviniemi, M.Nissinen, M.T.Lamsa, J.Jalonen, K.Rissanen, J.Pursiainen|2000|New J.Chem.|24|47|doi:10.1039/a907608e

18-Crown-6 bis(imidazolium) clathrate diperchlorateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)LipoproteinsEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Familial hypercholesterolemia030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicinePandemicInternal MedicinemedicineHumansHyperlipoproteinemia Type IILife StylePandemicsLetter to the Editor030304 developmental biology0303 health sciencesNutrition and DieteticsSARS-CoV-2Life stylebusiness.industryHomozygoteCOVID-19medicine.diseaseImmunologyBlood Component RemovalCardiology and Cardiovascular MedicinebusinessLipoprotein apheresisJournal of Clinical Lipidology
researchProduct

Mossbauer spectroscopic study of the thermal spin crossover in [Fe(II)(isoxazole)(6)](ClO(4))(2)

2008

The (57)Fe Mossbauer spectroscopy of mononuclear [Fe(II)(isoxazole)(6)](ClO(4))(2) has been studied to reveal the thermal spin crossover of Fe(II) between low-spin (S = 0) and high-spin (S = 2) states.Temperature-dependent spin transition curves have been constructed with the least-square fitted data obtained from the Mossbauer spectra measured at various temperatures between 84 and 270 K during a cooling and heating cycle. This compound exhibits an unusual temperature-dependent spin transition behaviour with T(C)(down arrow) = 223 and T(C)(up arrow) = 213 K occurring in the reverse order in comparison to those observed in SQUID observation and many other spin transition compounds. The comp…

5-BIS(PYRIDIN-2-YL)-1Phase transitionMossbauer spectroscopySpin transition2Inorganic compoundsABPT=4-AMINO-3chemistry.chemical_compoundMOLECULESNuclear magnetic resonanceSpin crossoverMössbauer spectroscopyMagnetic propertiesPERCHLORATEGeneral Materials Science4-TRIAZOLEIsoxazoleSpin (physics)Mössbauer effectORDER-DISORDER PHENOMENABIS(3-AMINOPROPYL)(2-PYRIDYLMETHYL)AMINECOMPOUNDGeneral ChemistryAtmospheric temperature rangeCondensed Matter PhysicsSTATECrystallographychemistryPhase transitionsPHASE-TRANSITIONCondensed Matter::Strongly Correlated ElectronsCOMPLEXESLIGANDSABPT=4-AMINO-35-BIS(PYRIDIN-2-YL)-124-TRIAZOLEJournal of Physics and Chemistry of Solids
researchProduct

CCDC 658958: Experimental Crystal Structure Determination

2007

Related Article: B.Verdejo, A.Ferrer, S.Blasco, C.E.Castillo, J.Gonzalez, J.Latorre, M.A.Manez, M.G.Basallote, C.Soriano, E.Garcia-Espana|2007|Inorg.Chem.|46|5707|doi:10.1021/ic700643n

6-(2-(Naphthylmethyamino)ethyl)-6915-triaza-3-azoniabicyclo(9.3.1)pentadeca-1(15)1113-triene perchlorate monohydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1827336: Experimental Crystal Structure Determination

2018

Related Article: Álvaro Martínez-Camarena, Andrea Liberato, Estefanía Delgado-Pinar, Andrés G. Algarra, Javier Pitarch-Jarque, José M. Llinares, M. Ángeles Mañez, Antonio Domenech-Carbó, Manuel G. Basallote, Enrique García-España|2018|Inorg.Chem.|57|10961|doi:10.1021/acs.inorgchem.8b01492

6-methyl-39-bis(propan-2-yl)-36915-tetraazabicyclo[9.3.1]pentadeca-1(15)1113-trien-6-ium perchlorate hemihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 177547: Experimental Crystal Structure Determination

2003

Related Article: R.K.O.Sigel, E.Freisinger, M.Abbate, B.Lippert|2002|Inorg.Chim.Acta|339|355|doi:10.1016/S0020-1693(02)00962-3

79-Dimethylguaninium perchlorate hemihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1861403: Experimental Crystal Structure Determination

2019

Related Article: Sujoy Das, Kari Rissanen, and Prithidipa Sahoo|2019|ACS Omega|4|5270|doi:10.1021/acsomega.9b00053

8-(2-((2-(2-(6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl)benzamido)ethyl)amino)-2-oxoethoxy)quinolin-1-ium bis(perchlorate) dihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct